Symptom management in gynecologic malignancies

References

• von Gruenigen VE, Huang HQ, Gil KM et al. Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials. Cancer115(20), 4857–4864 (2009).
   PubMed Web of Science ®Google Scholar
• Portenoy RK, Kornblith AB, Wong G et al. Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms. Cancer74(3), 907–915 (1994).
   PubMed Web of Science ®Google Scholar
• Liu S, Ercolano E, Siefert ML, McCorkle R. Patterns of symptoms in women after gynecologic surgery. Oncol. Nurs. Forum37(2), E133–E140 (2010).
   PubMedGoogle Scholar
• Steele R, Fitch MI. Supportive care needs of women with gynecologic cancer. Cancer Nurs.31(4), 284–291 (2008).
   PubMed Web of Science ®Google Scholar
• Ferrell B, Smith SL, Cullinane CA, Melancon C. Psychological well being and quality of life in ovarian cancer survivors. Cancer98(5), 1061–1071 (2003).
   PubMed Web of Science ®Google Scholar
• Sun CC, Bodurka DC, Weaver CB et al. Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer. Support Care Cancer13(4), 219–227 (2005).
   PubMed Web of Science ®Google Scholar
• von Gruenigen VE, Hutchins JR, Reidy AM et al. Gynecologic oncology patients’ satisfaction and symptom severity during palliative chemotherapy. Health Qual. Life Outcomes4, 84 (2006).
   PubMedGoogle Scholar
• Fieler VK. Side effects and quality of life in patients receiving high-dose rate brachytherapy. Oncol. Nurs. Forum24(3), 545–553 (1997).
   PubMedGoogle Scholar
• Wenzel LB, Donnelly JP, Fowler JM et al. Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study. Psychooncology11(2), 142–153 (2002).
   PubMed Web of Science ®Google Scholar
• Onsrud M, Hagen B, Heimstad R. [Palliative treatment in gynecologic cancer]. Tidsskr Nor Laegeforen121(16), 1896–1901 (2001).
   PubMedGoogle Scholar
• Houck K, Avis NE, Gallant JM, Fuller AF Jr, Goodman A. Quality of life in advanced ovarian cancer: identifying specific concerns. J. Palliat. Med.2(4), 397–402 (1999).
   PubMedGoogle Scholar
• Hodgkinson K, Butow P, Fuchs A et al. Long-term survival from gynecologic cancer: psychosocial outcomes, supportive care needs and positive outcomes. Gynecol. Oncol.104(2), 381–389 (2007).
   PubMed Web of Science ®Google Scholar
• Beesley V, Eakin E, Steginga S, Aitken J, Dunn J, Battistutta D. Unmet needs of gynaecological cancer survivors: implications for developing community support services. Psychooncology17(4), 392–400 (2008).
   PubMed Web of Science ®Google Scholar
• Klee M, Thranov I, Machin D. Life after radiotherapy: the psychological and social effects experienced by women treated for advanced stages of cervical cancer. Gynecol. Oncol.76(1), 5–13 (2000).
   PubMed Web of Science ®Google Scholar
• Miller BE, Pittman B, Strong C. Gynecologic cancer patients’ psychosocial needs and their views on the physician’s role in meeting those needs. Int. J. Gynecol. Cancer13(2), 111–119 (2003).
   PubMed Web of Science ®Google Scholar
• Wenzel L, DeAlba I, Habbal R et al. Quality of life in long-term cervical cancer survivors. Gynecol. Oncol.97(2), 310–317 (2005).
   PubMed Web of Science ®Google Scholar
• Capelli G, De Vincenzo RI, Addamo A, Bartolozzi F, Braggio N, Scambia G. Which dimensions of health-related quality of life are altered in patients attending the different gynecologic oncology health care settings? Cancer95(12), 2500–2507 (2002).
   PubMedGoogle Scholar
• Chan YM, Ngan HY, Li BY et al. A longitudinal study on quality of life after gynecologic cancer treatment. Gynecol. Oncol.83(1), 10–19 (2001).
   PubMed Web of Science ®Google Scholar
• Approaching death: improving care at the end of life – a report of the Institute of Medicine. Health Serv. Res.33(1), 1–3 (1998).
   PubMed Web of Science ®Google Scholar
• Ferris FD, Bruera E, Cherny N et al. Palliative cancer care a decade later: accomplishments, the need, next steps – from the American Society of Clinical Oncology. J. Clin. Oncol.27(18), 3052–3058 (2009).
   PubMed Web of Science ®Google Scholar
• Meier DE. Palliative care in hospitals. J. Hosp. Med.1(1), 21–28 (2006).
   PubMed Web of Science ®Google Scholar
• Hilden JM, Emanuel EJ, Fairclough DL et al. Attitudes and practices among pediatric oncologists regarding end-of-life care: results of the 1998 American Society of Clinical Oncology survey. J. Clin. Oncol.19(1), 205–212 (2001).
   PubMed Web of Science ®Google Scholar
• Ramondetta LM, Tortolero-Luna G, Bodurka DC et al. Approaches for end-of-life care in the field of gynecologic oncology: an exploratory study. Int. J. Gynecol. Cancer14(4), 580–588 (2004).
   PubMedGoogle Scholar
• Emanuel LLFF, von Gunten CF, Von Roenn J. EPEC-O: education in palliative and end-of-life care – oncology. In: The EPEC Project. Chicago, IL, USA (2005).
   Google Scholar
• Kirkova J, Davis MP, Walsh D et al. Cancer symptom assessment instruments: a systematic review. J. Clin. Oncol.24(9), 1459–1473 (2006).
   PubMed Web of Science ®Google Scholar
• Portenoy RK, Thaler HT, Kornblith AB et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur. J. Cancer30A(9), 1326–1336 (1994).
   PubMed Web of Science ®Google Scholar
• de Haes JC, van Knippenberg FC, Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br. J. Cancer62(6), 1034–1038 (1990).
   PubMed Web of Science ®Google Scholar
• Sitzia J, Dikken C, Hughes J. Psychometric evaluation of a questionnaire to document side-effects of chemotherapy. J. Adv. Nurs.25(5), 999–1007 (1997).
   PubMedGoogle Scholar
• Youngblood M, Williams PD, Eyles H, Waring J, Runyon S. A comparison of two methods of assessing cancer therapy-related symptoms. Cancer Nurs.17(1), 37–44 (1994).
   PubMedGoogle Scholar
• Munro AJ, Potter S. A quantitative approach to the distress caused by symptoms in patients treated with radical radiotherapy. Br. J. Cancer74(4), 640–647 (1996).
   PubMedGoogle Scholar
• Cleeland CS, Mendoza TR, Wang XS et al. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer89(7), 1634–1646 (2000).
   PubMed Web of Science ®Google Scholar
• Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J. Palliat. Care7(2), 6–9 (1991).
   PubMedGoogle Scholar
• McCorkle R, Young K. Development of a symptom distress scale. Cancer Nurs.1(5), 373–378 (1978).
   PubMedGoogle Scholar
• Ewing G, Todd C, Rogers M, Barclay S, McCabe J, Martin A. Validation of a symptom measure suitable for use among palliative care patients in the community: CAMPAS-R. J. Pain Symptom Manag.27(4), 287–299 (2004).
   PubMedGoogle Scholar
• Chang VT, Hwang SS, Kasimis B, Thaler HT. Shorter symptom assessment instruments: the Condensed Memorial Symptom Assessment Scale (CMSAS). Cancer Invest.22(4), 526–536 (2004).
   PubMed Web of Science ®Google Scholar
• Agarwal S, Bodurka DC. Symptom research in gynecologic oncology: a review of available measurement tools. Gynecol. Oncol.119(2), 384–389 (2010).
   PubMedGoogle Scholar
• Basen-Engquist K, Bodurka-Bevers D, Fitzgerald MA et al. Reliability and validity of the functional assessment of cancer therapy-ovarian. J. Clin. Oncol.19(6), 1809–1817 (2001).
   PubMed Web of Science ®Google Scholar
• Cella DF, Tulsky DS, Gray G et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J. Clin. Oncol.11(3), 570–579 (1993).
   PubMed Web of Science ®Google Scholar
• Greimel ER, Kuljanic Vlasic K, Waldenstrom AC et al. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24. Cancer107(8), 1812–1822 (2006).
   PubMed Web of Science ®Google Scholar
• Ditto A, Martinelli F, Borreani C et al. Quality of life and sexual, bladder, and intestinal dysfunctions after class III nerve-sparing and class II radical hysterectomies: a questionnaire-based study. Int. J. Gynecol. Cancer19(5), 953–957 (2009).
   PubMed Web of Science ®Google Scholar
• Janda M, Obermair A, Cella D et al. The functional assessment of cancer-vulvar: reliability and validity. Gynecol. Oncol.97(2), 568–575 (2005).
   PubMedGoogle Scholar
• Emanuel EJ, Emanuel LL. The promise of a good death. Lancet351(Suppl. 2), SII21–SII29 (1998).
   PubMed Web of Science ®Google Scholar
• Suzuki T, Morishita M, Ito E, Matsuura M, Tanaka R, Saito T. Analgesic efficacy of controlled-release oxycodone in patients with uterine or ovarian cancer. Am. J. Ther.15(1), 31–35 (2008).
   PubMedGoogle Scholar
• Ward S, Donovan HS, Owen B, Grosen E, Serlin R. An individualized intervention to overcome patient-related barriers to pain management in women with gynecologic cancers. Res. Nurs. Health23(5), 393–405 (2000).
   PubMedGoogle Scholar
• Weiss SC, Emanuel LL, Fairclough DL, Emanuel EJ. Understanding the experience of pain in terminally ill patients. Lancet357(9265), 1311–1315 (2001).
   PubMed Web of Science ®Google Scholar
• Portenoy RK, Thaler HT, Kornblith AB et al. Symptom prevalence, characteristics and distress in a cancer population. Qual. Life Res.3(3), 183–189 (1994).
   PubMed Web of Science ®Google Scholar
• Reddy S, Hui D, El Osta B et al. The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study. J. Palliat. Med.13(1), 33–38 (2010).
   PubMed Web of Science ®Google Scholar
• Portenoy RK, Sibirceva U, Smout R et al. Opioid use and survival at the end of life: a survey of a hospice population. J. Pain Symptom Manage.32(6), 532–540 (2006).
   PubMedGoogle Scholar
• Bengoechea I, Gutierrez SG, Vrotsou K, Onaindia MJ, Lopez JM. Opioid use at the end of life and survival in a Hospital at Home unit. J. Palliat. Med.13(9), 1079–1083 (2010).
   PubMedGoogle Scholar
• Plews-Ogan M, Owens JE, Goodman M, Wolfe P, Schorling J. A pilot study evaluating mindfulness-based stress reduction and massage for the management of chronic pain. J. Gen. Intern. Med.20(12), 1136–1138 (2005).
   PubMed Web of Science ®Google Scholar
• Kutner JS, Smith MC, Corbin L et al. Massage therapy versus simple touch to improve pain and mood in patients with advanced cancer: a randomized trial. Ann. Intern. Med.149(6), 369–379 (2008).
   PubMed Web of Science ®Google Scholar
• Alimi D, Rubino C, Pichard-Leandri E, Fermand-Brule S, Dubreuil-Lemaire ML, Hill C. Analgesic effect of auricular acupuncture for cancer pain: a randomized, blinded, controlled trial. J. Clin. Oncol.21(22), 4120–4126 (2003).
   PubMed Web of Science ®Google Scholar
• Searle RD, Bennett MI, Johnson MI, Callin S, Radford H. Letter to editor: transcutaneous electrical nerve stimulation (TENS) for cancer bone pain. Palliat. Med.22(7), 878–879 (2008).
   PubMedGoogle Scholar
• Abrams DI, Jay CA, Shade SB et al. Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology68(7), 515–521 (2007).
   PubMed Web of Science ®Google Scholar
• Irvine D, Vincent L, Graydon JE, Bubela N, Thompson L. The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. Cancer Nurs.17(5), 367–378 (1994).
   PubMed Web of Science ®Google Scholar
• Greenberg DB, Sawicka J, Eisenthal S, Ross D. Fatigue syndrome due to localized radiation. J. Pain Symptom Manage.7(1), 38–45 (1992).
   PubMed Web of Science ®Google Scholar
• Vogelzang NJ, Breitbart W, Cella D et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin. Hematol.34(3 Suppl. 2), 4–12 (1997).
   PubMed Web of Science ®Google Scholar
• Holzner B, Kemmler G, Meraner V et al. Fatigue in ovarian carcinoma patients: a neglected issue? Cancer97(6), 1564–1572 (2003).
   PubMed Web of Science ®Google Scholar
• Portenoy RK, Itri LM. Cancer-related fatigue: guidelines for evaluation and management. Oncologist4(1), 1–10 (1999).
   PubMedGoogle Scholar
• Sugawara Y, Akechi T, Shima Y et al. Efficacy of methylphenidate for fatigue in advanced cancer patients: a preliminary study. Palliat. Med.16(3), 261–263 (2002).
   PubMedGoogle Scholar
• Bruera E, Driver L, Barnes EA et al. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J. Clin. Oncol.21(23), 4439–4443 (2003).
   PubMed Web of Science ®Google Scholar
• Bruera E, Valero V, Driver L et al. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J. Clin. Oncol.24(13), 2073–2078 (2006).
   PubMed Web of Science ®Google Scholar
• Johnson RL, Block I, Gold MA, Markwell S, Zupancic M. Effect of methylphenidate on fatigue in women with recurrent gynecologic cancer. Psychooncology19(9), 955–958 (2009).
   Google Scholar
• Bruera E, Roca E, Cedaro L, Carraro S, Chacon R. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat. Rep.69(7–8), 751–754 (1985).
   PubMedGoogle Scholar
• Tannock I, Gospodarowicz M, Meakin W, Panzarella T, Stewart L, Rider W. Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response. J. Clin. Oncol.7(5), 590–597 (1989).
   PubMed Web of Science ®Google Scholar
• Barton DL, Soori GS, Bauer BA et al. Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Support Care Cancer18(2), 179–187 (2010).
   PubMed Web of Science ®Google Scholar
• Cramp F, Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst. Rev.2, CD006145 (2008).
   Google Scholar
• Thomas J, Karver S, Cooney GA et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N. Engl. J. Med.358(22), 2332–2343 (2008).
   PubMed Web of Science ®Google Scholar
• Grunberg SM, Rolski J, Strausz J et al. Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial. Lancet Oncol.10(6), 549–558 (2009).
   PubMed Web of Science ®Google Scholar
• Gan TJ, Gu J, Singla N et al. Rolapitant for the prevention of postoperative nausea and vomiting: a prospective, double-blinded, placebo-controlled randomized trial. Anesth. Analg.112(4), 804–812 (2011).
   PubMed Web of Science ®Google Scholar
• Tramer MR, Carroll D, Campbell FA, Reynolds DJ, Moore RA, McQuay HJ. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ323(7303), 16–21 (2001).
   PubMed Web of Science ®Google Scholar
• Pillai AK, Sharma KK, Gupta YK, Bakhshi S. Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy. Pediatr. Blood Cancer56(2), 234–238 (2011).
   PubMed Web of Science ®Google Scholar
• Pearl ML, Fischer M, McCauley DL, Valea FA, Chalas E. Transcutaneous electrical nerve stimulation as an adjunct for controlling chemotherapy-induced nausea and vomiting in gynecologic oncology patients. Cancer Nurs.22(4), 307–311 (1999).
   PubMed Web of Science ®Google Scholar
• Chi DS, Phaeton R, Miner TJ et al. A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer. Oncologist14(8), 835–839 (2009).
   PubMed Web of Science ®Google Scholar
• Ryan M, Stainton MC, Jaconelli C, Watts S, MacKenzie P, Mansberg T. The experience of lower limb lymphedema for women after treatment for gynecologic cancer. Oncol. Nurs. Forum30(3), 417–423 (2003).
   PubMedGoogle Scholar
• Ryan M, Stainton MC, Slaytor EK, Jaconelli C, Watts S, Mackenzie P. Aetiology and prevalence of lower limb lymphoedema following treatment for gynaecological cancer. Aust. NZJ Obstet. Gynaecol.43(2), 148–151 (2003).
   PubMed Web of Science ®Google Scholar
• Gould N, Kamelle S, Tillmanns T et al. Predictors of complications after inguinal lymphadenectomy. Gynecol. Oncol.82(2), 329–332 (2001).
   PubMed Web of Science ®Google Scholar
• Beesley V, Janda M, Eakin E, Obermair A, Battistutta D. Lymphedema after gynecological cancer treatment: prevalence, correlates, and supportive care needs. Cancer109(12), 2607–2614 (2007).
   PubMed Web of Science ®Google Scholar
• Carlson JW, Kauderer J, Walker JL et al. A randomized Phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: a Gynecologic Oncology Group study. Gynecol. Oncol.110(1), 76–82 (2008).
   PubMed Web of Science ®Google Scholar
• Kanakura Y, Niwa K, Kometani K et al. Effectiveness of acupuncture and moxibustion treatment for lymphedema following intrapelvic lymph node dissection: a preliminary report. Am. J. Chin. Med.30(1), 37–43 (2002).
   PubMedGoogle Scholar
• Schmitz KH, Ahmed RL, Troxel A et al. Weight lifting in women with breast-cancer-related lymphedema. N. Engl. J. Med.361(7), 664–673 (2009).
   PubMed Web of Science ®Google Scholar
• Schmitz KH, Ahmed RL, Troxel AB et al. Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA304(24), 2699–2705 (2010).
   PubMed Web of Science ®Google Scholar
• Parsons SL, Watson SA, Steele RJ. Malignant ascites. Br. J. Surg.83(1), 6–14 (1996).
   PubMed Web of Science ®Google Scholar
• Becker G, Galandi D, Blum HE. Malignant ascites: systematic review and guideline for treatment. Eur. J. Cancer42(5), 589–597 (2006).
   PubMed Web of Science ®Google Scholar
• Stuart GC, Nation JG, Snider DD, Thunberg P. Intraperitoneal interferon in the management of malignant ascites. Cancer71(6), 2027–2030 (1993).
   PubMedGoogle Scholar
• Lee CW, Bociek G, Faught W. A survey of practice in management of malignant ascites. J. Pain Symptom Manage.16(2), 96–101 (1998).
   PubMed Web of Science ®Google Scholar
• Faught W, Kirkpatrick JR, Krepart GV, Heywood MS, Lotocki RJ. Peritoneovenous shunt for palliation of gynecologic malignant ascites. J. Am. Coll. Surg.180(4), 472–474 (1995).
   PubMedGoogle Scholar
• Khabele D, Runowicz CD, Fields AL, Anderson PS, Goldberg GL. Evaluation of low-dose intraperitoneal interferon-α for palliation of ascites in patients with non-ovarian gynecologic malignancies. Gynecol. Oncol.89(3), 420–423 (2003).
   PubMedGoogle Scholar
• Kobold S, Hegewisch-Becker S, Oechsle K, Jordan K, Bokemeyer C, Atanackovic D. Intraperitoneal VEGF inhibition using bevacizumab: a potential approach for the symptomatic treatment of malignant ascites? Oncologist14(12), 1242–1251 (2009).
   PubMedGoogle Scholar
• Valente SM, Saunders JM, Cohen MZ. Evaluating depression among patients with cancer. Cancer Pract.2(1), 65–71 (1994).
   PubMedGoogle Scholar
• Chochinov HM, Wilson KG, Enns M, Lander S. ‘Are you depressed?’ Screening for depression in the terminally ill. Am. J. Psychiatry154(5), 674–676 (1997).
   PubMed Web of Science ®Google Scholar
• Fisch M. Treatment of depression in cancer. J. Natl Cancer Inst. Monogr.32, 105–111 (2004).
   PubMedGoogle Scholar
• Ell K, Sanchez K, Vourlekis B et al. Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer. J. Clin. Oncol.23(13), 3052–3060 (2005).
   PubMed Web of Science ®Google Scholar
• Shalev AY, Schreiber S, Galai T, Melmed RN. Post-traumatic stress disorder following medical events. Br. J. Clin. Psychol.32(Pt 2), 247–253 (1993).
   PubMed Web of Science ®Google Scholar
• Berard RM. Depression and anxiety in oncology: the psychiatrist’s perspective. J. Clin. Psychiatry62(Suppl. 8), 58–61; discussion 62–53 (2001).
   PubMed Web of Science ®Google Scholar
• Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L. Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur. J. Cancer30A(1), 37–40 (1994).
   PubMed Web of Science ®Google Scholar
• Cella DF, Jacobsen PB, Orav EJ, Holland JC, Silberfarb PM, Rafla S. A brief POMS measure of distress for cancer patients. J. Chronic Dis.40(10), 939–942 (1987).
   PubMedGoogle Scholar
• Powell CB, Kneier A, Chen LM, Rubin M, Kronewetter C, Levine E. A randomized study of the effectiveness of a brief psychosocial intervention for women attending a gynecologic cancer clinic. Gynecol. Oncol.111(1), 137–143 (2008).
   PubMed Web of Science ®Google Scholar
• Leon-Pizarro C, Gich I, Barthe E et al. A randomized trial of the effect of training in relaxation and guided imagery techniques in improving psychological and quality-of-life indices for gynecologic and breast brachytherapy patients. Psychooncology16(11), 971–979 (2007).
   PubMed Web of Science ®Google Scholar
• Cain EN, Kohorn EI, Quinlan DM, Latimer K, Schwartz PE. Psychosocial benefits of a cancer support group. Cancer57(1), 183–189 (1986).
   PubMed Web of Science ®Google Scholar
• Hersch J, Juraskova I, Price M, Mullan B. Psychosocial interventions and quality of life in gynaecological cancer patients: a systematic review. Psychooncology18(8), 795–810 (2009).
   PubMed Web of Science ®Google Scholar
• Wilmoth MC, Botchway P. Psychosexual implications of breast and gynecologic cancer. Cancer Invest.17(8), 631–636 (1999).
   PubMed Web of Science ®Google Scholar
• Aerts L, Enzlin P, Verhaeghe J, Vergote I, Amant F. Sexual and psychological functioning in women after pelvic surgery for gynaecological cancer. Eur. J. Gynaecol. Oncol.30(6), 652–656 (2009).
   PubMed Web of Science ®Google Scholar
• Andersen BL, Woods XA, Copeland LJ. Sexual self-schema and sexual morbidity among gynecologic cancer survivors. J. Consult. Clin. Psychol.65(2), 221–229 (1997).
   PubMed Web of Science ®Google Scholar
• Frumovitz M, Sun CC, Schover LR et al. Quality of life and sexual functioning in cervical cancer survivors. J. Clin. Oncol.23(30), 7428–7436 (2005).
   PubMed Web of Science ®Google Scholar
• Carmack Taylor CL, Basen-Engquist K, Shinn EH, Bodurka DC. Predictors of sexual functioning in ovarian cancer patients. J. Clin. Oncol.22(5), 881–889 (2004).
   PubMed Web of Science ®Google Scholar
• Green MS, Naumann RW, Elliot M, Hall JB, Higgins RV, Grigsby JH. Sexual dysfunction following vulvectomy. Gynecol. Oncol.77(1), 73–77 (2000).
   PubMed Web of Science ®Google Scholar
• Juraskova I, Butow P, Robertson R, Sharpe L, McLeod C, Hacker N. Post-treatment sexual adjustment following cervical and endometrial cancer: a qualitative insight. Psychooncology12(3), 267–279 (2003).
   PubMed Web of Science ®Google Scholar
• Carter J, Rowland K, Chi D et al. Gynecologic cancer treatment and the impact of cancer-related infertility. Gynecol. Oncol.97(1), 90–95 (2005).
   PubMed Web of Science ®Google Scholar
• Carter J, Chi DS, Brown CL et al. Cancer-related infertility in survivorship. Int. J. Gynecol. Cancer20(1), 2–8 (2010).
   PubMed Web of Science ®Google Scholar
• Carter J, Raviv L, Applegarth L et al. A cross-sectional study of the psychosexual impact of cancer-related infertility in women: third-party reproductive assistance. J. Cancer Surviv.4(3), 236–246 (2010).
   PubMed Web of Science ®Google Scholar
• Brotto LA, Heiman JR, Goff B et al. A psychoeducational intervention for sexual dysfunction in women with gynecologic cancer. Arch. Sex. Behav.37(2), 317–329 (2008).
   PubMed Web of Science ®Google Scholar
• Amsterdam A, Krychman ML. Sexual dysfunction in patients with gynecologic neoplasms: a retrospective pilot study. J. Sex Med.3(4), 646–649 (2006).
   PubMed Web of Science ®Google Scholar
• Morrison RS, Penrod JD, Cassel JB et al. Cost savings associated with US hospital palliative care consultation programs. Arch. Intern. Med.168(16), 1783–1790 (2008).
   PubMed Web of Science ®Google Scholar
• Goldsmith B, Dietrich J, Du Q, Morrison RS. Variability in access to hospital palliative care in the United States. J. Palliat. Med.11(8), 1094–1102 (2008).
   PubMed Web of Science ®Google Scholar
• Temel JS, Greer JA, Muzikansky A et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N. Engl. J. Med.363(8), 733–742 (2010).
   PubMed Web of Science ®Google Scholar